secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kiniksa Pharmaceuticals International, plc (KNSA)
CIK:        0001730430
Form:       8-K
Filed at:   2026-01-14T23:59:59+00:00
Accession:  0001730430-26-000010
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Kiniksa appoints Ross Moat as COO and Eben Tessari as Chief Strategy Officer
----------------------------------------------------------------------------

- Ross Moat promoted to COO effective Jan 10, 2026; will oversee commercial and functional operations.
- Eben Tessari appointed Chief Strategy Officer effective Jan 10, 2026; adds AI initiatives to strategy and BD.
- No changes to compensation for either executive in connection with the appointments.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1730430/000173043026000010/0001730430-26-000010-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1730430/000173043026000010/knsa-20260110x8k.htm
  HTML page:      https://secwatch.observer/filing/0001730430-26-000010

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer